GOWEN MAXINE bought ACRS
June 4, 2026 · Form 4 insider transaction
GOWEN MAXINE bought 42,350 shares of Aclaris Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
42,350
Price
$0.00
Total value
N/A
InsiderGOWEN MAXINE
RoleDirector
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateJune 4, 2026
Filing dateJune 8, 2026
Shares owned after42,350
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The shares subject to this stock option will vest in twelve equal monthly installments commencing on July 4, 2026, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2025 Equity Incentive Plan, or the Plan) through each such vesting date.; This grant was made pursuant to the issuer's tenth amended and restated non-employee director compensation policy.